Wordt geladen...
Checkpoint Inhibition in Myeloma: Opportunities and Challenges
Despite major improvements in the treatment landscape, most multiple myeloma (MM) patients eventually succumb to the underlying malignancy. Immunotherapy represents an attractive strategy to achieve durable remissions due to its specificity and capacity for long term memory. Activation of immune cel...
Bewaard in:
| Gepubliceerd in: | Front Immunol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168958/ https://ncbi.nlm.nih.gov/pubmed/30319648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02204 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|